lenalidomide has been researched along with Plasmacytoma in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 14 (60.87) | 24.3611 |
| 2020's | 9 (39.13) | 2.80 |
| Authors | Studies |
|---|---|
| Chiba, A; Honda, A; Ikemura, M; Kurokawa, M; Maki, H; Masamoto, Y; Oyama, T; Taoka, K | 1 |
| Akiyama, H; Fujimori, C; Hagino, T; Hidai, H; Kurimoto, M; Motomura, S; Murai, Y; Osanai, S; Saga, R; Sano, S | 1 |
| Arsène-Henry, A; Bouscary, D; Kirova, Y; Mignot, F; Schernberg, A; Vignon, M | 1 |
| Yazici, G; Yuce Sari, S | 1 |
| Kirova, Y; Mignot, F | 1 |
| Arai, H; Handa, T; Ichikawa, M; Mitani, K; Nakamura, F; Nakamura, Y; Okazaki, A; Sasaki, K; Seo, S; Takahashi, W | 1 |
| Kocoglu, M; Li, A; Nageshwar, M; Sanchez-Petitto, G; Singh, Z; Tkaczuk, KHR | 1 |
| Andres, M; Angelillo-Scherrer, A; Dickenmann, M; Jalowiec, KA; Kremer Hovinga, JA; Musa, A; Rovó, A; Taleghani, BM | 1 |
| Anderson, KC; Badros, A; Beksac, M; Bladé, J; Caers, J; Cavo, M; Dimopoulos, MA; Dispenzieri, A; Einsele, H; Engelhardt, M; Fernández de Larrea, C; Gahrton, G; Gay, F; Hájek, R; Hungria, V; Jurczyszyn, A; Kröger, N; Kyle, RA; Leal da Costa, F; Leleu, X; Lentzsch, S; Mateos, MV; Merlini, G; Mohty, M; Moreau, P; Rasche, L; Reece, D; Richardson, PG; Rosiñol, L; Sezer, O; Sonneveld, P; Usmani, SZ; Van de Donk, NWCJ; Vanderkerken, K; Vesole, DH; Waage, A; Zamagni, E; Zweegman, S | 1 |
| Abuomar, W; Al Sughaiyer, H; Al-Mayoof, O; Khan, M | 1 |
| Gamez, R; Jawahar, A; Nagamine, A | 1 |
| Cavenagh, J; Ingram, W; Quinn, J; Smith, D; Stevens, J; Yong, K | 1 |
| Demopoulos, AM; Devoe, CE; Li, JY | 1 |
| Ali, SM; Chmielecki, J; Miller, VA; Morosini, D; Palmer, GA; Ross, JS; Sharman, JP; Stafl, J; Stephens, PJ | 1 |
| Bjorklund, CC; Corchete, LA; Couto, S; Delgado, M; Díaz-Rodríguez, E; Fernández-Lázaro, D; Garayoa, M; García-Gómez, A; Gutiérrez, NC; López-Corral, L; Mateos, MV; Montero, JC; Ocio, EM; Paíno, T; Pandiella, A; San-Miguel, JF; San-Segundo, L; Wang, M | 1 |
| Anderson, KC; Ghobrial, IM; Laubach, J; Maglio, ME; Mitsiades, CS; Munshi, NC; O'Donnell, EK; Paba-Prada, C; Raje, N; Richardson, PG; Schlossman, R; Varga, C; Warren, D; Weinstock, M; Weller, E; Xie, W | 1 |
| Alsina, M; Horna, P; Kharfan-Dabaja, MA; Nishihori, T; Salem, KZ | 1 |
| Egner, JR; Khaliq, W; Konchanin, RP; Sapiente, RA; Uzoaru, I | 1 |
| Theodorescu, D; Wilson, SS | 1 |
| Frosch, P; Grape, J | 1 |
| Aisa, Y; Ito, C; Mihara, A; Nakazato, T; Sanada, Y | 1 |
| Fukushima, T; Iwao, H; Nakamura, T; Umehara, H | 1 |
| Arima, N; Kawada, H | 1 |
4 review(s) available for lenalidomide and Plasmacytoma
| Article | Year |
|---|---|
Acquired hemophilia A and plasma cell neoplasms: a case report and review of the literature.
Topics: Aged; Factor VIII; Hemophilia A; Humans; Lenalidomide; Male; Multiple Myeloma; Plasmacytoma; Thalidomide | 2020 |
Expert review on soft-tissue plasmacytomas in multiple myeloma: definition, disease assessment and treatment considerations.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Bortezomib; Cisplatin; Cyclophosphamide; Dexamethasone; Disease Management; Doxorubicin; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Lenalidomide; Multiple Myeloma; Plasmacytoma; Prognosis; Transplantation, Autologous | 2021 |
Rare bladder tumors: caveat emptor.
Topics: Abnormalities, Drug-Induced; Disease Progression; Female; Humans; Lenalidomide; Male; Multiple Myeloma; Plasmacytoma; Pregnancy; Radiotherapy; Salvage Therapy; Thalidomide; Urinary Bladder; Urinary Bladder Neoplasms | 2010 |
[Update on treatment of multiple myeloma: including myeloma kidney and molecular targeting drugs].
Topics: Boronic Acids; Bortezomib; Drug Design; Humans; Immunologic Factors; Kidney Neoplasms; Lenalidomide; Molecular Targeted Therapy; Multiple Myeloma; Oligopeptides; Plasmacytoma; Pyrazines; Thalidomide | 2012 |
19 other study(ies) available for lenalidomide and Plasmacytoma
| Article | Year |
|---|---|
Daratumumab plus lenalidomide and dexamethasone for relapsed POEMS syndrome with bone plasmacytoma harboring 17p deletion.
Topics: Dexamethasone; Hematopoietic Stem Cell Transplantation; Humans; Lenalidomide; Male; Plasmacytoma; POEMS Syndrome; Thalidomide; Transplantation, Autologous | 2023 |
[Multiple extramedullary plasmacytomas responding to a reduced dose of carfilzomib following drug-induced thrombotic microangiopathy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Dexamethasone; Humans; Lenalidomide; Leukemia, Plasma Cell; Male; Multiple Myeloma; Plasmacytoma; Recurrence; Thrombotic Microangiopathies | 2022 |
Solitary Plasmacytoma Treated by Lenalidomide-Dexamethasone in Combination with Radiation Therapy: Clinical Outcomes.
Topics: Adult; Aged; Antineoplastic Agents; Chemoradiotherapy; Dexamethasone; Disease-Free Survival; Drug Therapy, Combination; Female; Humans; Lenalidomide; Male; Middle Aged; Multiple Myeloma; Plasmacytoma; Progression-Free Survival; Radiotherapy, Intensity-Modulated; Survival Rate | 2020 |
In Regard to Mignot et al.
Topics: Bone Neoplasms; Dexamethasone; Humans; Lenalidomide; Plasmacytoma | 2020 |
In Reply to Sari and Yazici.
Topics: Bone Neoplasms; Dexamethasone; Humans; Lenalidomide; Plasmacytoma; Tumor Suppressor Proteins | 2020 |
[Effective treatment of POEMS syndrome accompanied by plasmacytoma with lenalidomide, dexamethasone, and local irradiation].
Topics: Aged; Dexamethasone; Female; Humans; Lenalidomide; Plasmacytoma; POEMS Syndrome; Vascular Endothelial Growth Factor A | 2020 |
An Unusual Cause of a Pathological Vertebral Fracture: Solitary Plasmacytoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bortezomib; Decompression, Surgical; Dexamethasone; Disease Progression; Female; Fractures, Compression; Fractures, Spontaneous; Humans; Humeral Fractures; Immunoglobulin A; Immunoglobulin G; Immunoglobulin M; Laminectomy; Lenalidomide; Multiple Myeloma; Plasmacytoma; Positron-Emission Tomography; Spinal Cord Compression; Spinal Fractures; Spinal Neoplasms; Thoracic Vertebrae; Tomography, X-Ray Computed | 2020 |
POEMS syndrome: a rare cause of exudative ascites and chronic peripheral neuropathy.
Topics: Adult; Ascites; Dexamethasone; Humans; Lenalidomide; Male; Myeloma Proteins; Paraproteinemias; Peripheral Nervous System Diseases; Plasmacytoma; POEMS Syndrome; Sacrum; Thalidomide | 2017 |
Breast plasmacytoma with associated amyloidosis mimicking breast carcinoma.
Topics: Amyloidosis; Aspirin; Breast Diseases; Breast Neoplasms; Female; Humans; Immunoglobulin G; Immunoglobulin M; Lenalidomide; Mammography; Middle Aged; Multiple Myeloma; Plasmacytoma; Ultrasonography, Mammary | 2018 |
Myeloma presenting during pregnancy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Cesarean Section; Chemoradiotherapy; Cisplatin; Combined Modality Therapy; Contraindications; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Fatal Outcome; Female; Hematopoietic Stem Cell Transplantation; Humans; Hypercalcemia; Idarubicin; Infant, Newborn; Lenalidomide; Male; Melphalan; Methylprednisolone; Multiple Myeloma; Myeloma Proteins; Osteolysis; Plasmacytoma; Postpartum Period; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Outcome; Pyrazines; Remission Induction; Spinal Cord Compression; Thalidomide; Thoracic Vertebrae; Transplantation, Autologous | 2014 |
The successful treatment of a recurrent intracranial, dural-based plasmacytoma with lenalidomide.
Topics: Aged; Angiogenesis Inhibitors; Brain Neoplasms; Female; Humans; Lenalidomide; Neoplasm Recurrence, Local; Plasmacytoma; Thalidomide; Treatment Outcome | 2014 |
Vemurafenib response in 2 patients with posttransplant refractory BRAF V600E-mutated multiple myeloma.
Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Carcinoma, Squamous Cell; Combined Modality Therapy; Dexamethasone; Disease Progression; Fatal Outcome; Hematopoietic Stem Cell Transplantation; Humans; Indoles; Lenalidomide; Male; Mediastinal Neoplasms; Middle Aged; Multiple Myeloma; Mutation, Missense; Neoplasm Proteins; Neoplasms, Second Primary; Osteolysis; Palliative Care; Plasmacytoma; Point Mutation; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Pyrazines; Remission Induction; Salvage Therapy; Sulfonamides; Thalidomide; Transplantation, Autologous; Treatment Outcome; Vemurafenib | 2014 |
In vivo murine model of acquired resistance in myeloma reveals differential mechanisms for lenalidomide and pomalidomide in combination with dexamethasone.
Topics: Adaptor Proteins, Signal Transducing; Animals; Antineoplastic Agents; Apoptosis; Benzimidazoles; Cell Line, Tumor; Dexamethasone; Disease Models, Animal; Drug Resistance, Neoplasm; Drug Therapy, Combination; Extracellular Signal-Regulated MAP Kinases; Gene Expression Regulation, Neoplastic; Humans; Ikaros Transcription Factor; Lenalidomide; Mice; Multiple Myeloma; Neoplasm Transplantation; Nerve Tissue Proteins; Plasmacytoma; Signal Transduction; Thalidomide; Trans-Activators | 2015 |
Development of extramedullary myeloma in the era of novel agents: no evidence of increased risk with lenalidomide-bortezomib combinations.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Boronic Acids; Bortezomib; Female; Follow-Up Studies; Humans; Incidence; Lenalidomide; Male; Multiple Myeloma; Neoplasm Staging; Neoplasms, Second Primary; Plasmacytoma; Pyrazines; Remission Induction; Risk; Thalidomide; Treatment Outcome | 2015 |
Primary plasmacytoma involving mediastinal lymph nodes: A diagnostic mimicry of primary mediastinal lymphoma.
Topics: Angiogenesis Inhibitors; Antineoplastic Agents, Alkylating; Humans; Lenalidomide; Lymph Nodes; Male; Mediastinal Neoplasms; Mediastinum; Melphalan; Middle Aged; Plasma Cells; Plasmacytoma; Syndecan-1; Thalidomide | 2016 |
Solitary extramedullary plasmacytoma of the bladder: a case report and literature.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cystoscopy; Dexamethasone; Humans; Lenalidomide; Male; Plasmacytoma; Radiation Tolerance; Radiotherapy; Remission Induction; Thalidomide; Treatment Failure; Urinary Bladder; Urinary Bladder Neoplasms | 2010 |
[Papular drug eruption along the lines of Blaschko caused by lenalidomide].
Topics: Antineoplastic Agents; Diagnosis, Differential; Drug Eruptions; Humans; Leg Dermatoses; Lenalidomide; Male; Middle Aged; Patch Tests; Plasmacytoma; Skin Diseases, Papulosquamous; Thalidomide | 2011 |
Lenalidomide is active for extramedullary disease in refractory multiple myeloma.
Topics: Aged, 80 and over; Antineoplastic Agents; Humans; Lenalidomide; Male; Multiple Myeloma; Plasmacytoma; Sarcoma, Myeloid; Thalidomide | 2012 |
Rapid response of plasmacytomas to lenalidomide plus low-dose dexamethasone therapy in a patient with relapsed multiple myeloma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Dexamethasone; Female; Humans; Lenalidomide; Middle Aged; Multiple Myeloma; Plasmacytoma; Recurrence; Thalidomide | 2011 |